Logotype for Codexis Inc

Codexis (CDXS) investor relations material

Codexis Cantor Global Healthcare Conference 2025 summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Codexis Inc
Cantor Global Healthcare Conference 2025 summary4 Sep, 2025

Industry context and demand trends

  • siRNA therapeutics are gaining momentum, with projected demand rising from 100 kg in 2023 to potentially 50 metric tons or more by decade's end, driven by new entrants and expanding indications.

  • Current chemical synthesis methods for siRNA are inefficient, costly, and limited in scalability, creating a supply bottleneck for future high-volume needs.

  • Enzymatic synthesis is positioned as the only viable solution for meeting large-scale siRNA demand, with industry leaders and new players recognizing this shift.

  • Conferences like Tides have become key venues for showcasing technological advances and generating significant customer interest and leads.

  • The field is transitioning from chemical to chemoenzymatic and fully enzymatic manufacturing, with enzymatic methods enabling new product possibilities.

Technology and platform offerings

  • The company offers a flexible toolbox: ligation (chemoenzymatic), end-to-end enzymatic synthesis, and hybrid approaches tailored to customer needs.

  • Demonstrated ability to synthesize complex drugs like Inclisiran using multiple methods, including full enzymatic and hybrid processes.

  • Recent technical milestones include controlling molecular chirality and scaling up to 10 g, with plans to demonstrate 100 g at upcoming conferences.

  • Internal GMP facility commissioning is a near-term milestone, supporting clinical trial supply and customer confidence.

  • Enzymatic processes offer advantages in purity, scalability, and infrastructure simplicity, reducing costs and setup times compared to chemical methods.

Customer engagement and business model

  • Customer engagement spans from simple supply agreements for ligases to long-term development partnerships for the ECO Synthesis platform.

  • Contract structures vary: large pharma prefers cost-per-run models, while early-stage companies may involve royalties and shared upside.

  • The company is selective, targeting early-phase assets with high potential and credible management, aiming to lock in future revenue streams.

  • Customer conversion rates are high, with a growing pipeline and a focus on building long-term relationships.

  • The business model shifts from modest early-stage economics to significant revenue as drugs advance through clinical development and scale.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Codexis earnings date

Logotype for Codexis Inc
Q3 20256 Nov, 2025
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Codexis earnings date

Logotype for Codexis Inc
Q3 20256 Nov, 2025

The essential earnings season companion

The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Codexis, Inc. discovers, develops, and sells enzymes and other proteins to the pharmaceutical and renewable chemical industries. The company offers CodeEvolver protein engineering platform that involves designing of molecule, designing an enzyme to do the job, and optimizing the enzyme for industrial use in discovery drug safety evaluations (DSEs) market; CodeXyme enzyme for converting sugar into specialty chemicals; and enzymes for manufacturing APIs. It also provides enzymes for fuel ethanol industry.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage